DelMar Pharmaceuticals, Inc. – ‘8-A12G’ on 9/14/12

On:  Friday, 9/14/12, at 12:12pm ET   ·   Accession #:  1165527-12-979   ·   File #:  0-54801

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Registration of a Class of Securities   —   Form 8-A
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-A12G      Form 8-A of Berry Only Inc                             2     10K 
 2: EX-4        Speciman Stock Certificate                             2      8K 
 3: EX-99       Subscription Agreement                                11     41K 

8-A12G   —   Form 8-A of Berry Only Inc
Document Table of Contents

8-A12G
1st Page of 2
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
 UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-A

 FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
 PURSUANT TO SECTION 12(b) OR (g) OF THE
 SECURITIES EXCHANGE ACT OF 1934

 BERRY ONLY INC.
(Exact name of registrant as specified in its charter)

     Nevada                                         99-0360497
(State of incorporation or organization)       (IRS Employer Identification No.)

36 McLean Street
Red Bank, NJ 07701
 (Address and zip code of principal executive offices)

 Securities to be registered pursuant to Section 12(b) of the Act:

Title of each class                               Name of each exchange on which
To be so registered                               each class is to be registered
-------------------                               ------------------------------
Not Applicable                                            Not Applicable    

If this form relates to the registration of a class of securities pursuant to   
Section 12(b) of the Exchange Act and is effective pursuant to General          
Instruction A.(c) check the following box [ ]                                   

If this form relates to the registration of a class of securities pursuant to   
Section 12(g) of the Exchange Act and is effective pursuant to General          
Instruction A.(d) check the following box [X]                                   

Securities Act registration statement file number to which this form relates:   
333-168897                                                                      

Securities to be registered pursuant to Section 12(g) of the Act: 

 Common Stock, $.001 par value
(Title of Class)

8-A12G
Last Page of 2
TOC
1st
Previous
Next
↓Bottom
Just 2nd
INFORMATION REQUIRED IN REGISTRATION STATEMENT

ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED                 

The description of the Registrant's Common Stock included under the caption     
"Description of Securities" set forth in the Prospectus, Registration No.       
333-168897, filed with the Securities and Exchange Commission on August 17,     
2010, as further amended from time to time collectively, the ("Registration     
Statement"), is incorporated herein by reference.                               

ITEM 2. EXHIBITS                                                                

List below all exhibits filed as a part of the registration statement:          

3.1  Articles of Incorporation of Registrant (incorporated by reference herein  
from Exhibit 3.1 to Form S-1, Registration No. 333-168897)            

3.2  By-Laws of Registrant (incorporated by reference herein from Exhibit 3.2 to
Form S-1, Registration No. 333-168897)                                

4    Specimen Stock Certificate                                                 

99   Subscription Agreement                                                     

 SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of    
1934, the registrant has duly caused this registration statement to be signed on
its behalf by the undersigned, thereto duly authorized.                         

September 14, 2012                      Berry Only Inc., Registrant             

                  By: /s/ Lisa Guise
                                            ------------------------------------
                                         Lisa Guise, President, Secretary,
                                           Treasurer, Chief Executive Officer,
                                    Chief Financial Officer, and
                                    Principal Accounting Officer

2 

Dates Referenced Herein   and   Documents Incorporated by Reference

				Referenced-On Page
This ‘8-A12G’ Filing		Date		First		Last			Other Filings
Filed on:		9/14/12		2
		8/17/10		2					S-1
									List all Filings

4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/27/22  Kintara Therapeutics, Inc.        S-8         9/27/22    4:271K                                   Donnelley … Solutions/FA
 9/28/21  Kintara Therapeutics, Inc.        S-8         9/28/21    3:165K                                   ActiveDisclosure/FA
 3/24/21  Kintara Therapeutics, Inc.        S-3                    7:1.8M                                   ActiveDisclosure/FA
 9/21/20  Kintara Therapeutics, Inc.        S-8         9/21/20    4:191K                                   ActiveDisclosure/FA